Professional Documents
Culture Documents
Noradrenaline Dobutamine
Dopamine
NAHCO3
vassopressin
Lidocaine
Gluconate Calcium
Amiodarone
Adenosine
Atrophine
Epinephrine
Drug
Indication
Asystole, PEA, Pulseless
Vfib/Vtach
Anaphylaxis
Sinus bradycardia
Symptomatic
narrow
bradycardia
Asystole
Supraventricu
lar
Tachycardia
Pulseless
ventriculat
fibrillation or
ventricular
tachycardia
Atrial
Hypocalcemia
Severe
hyperkalemia
Severe
hypermagnes
aemia
CV drugs:
Antiarrhythmics
Anesthetic
Anesthesia
Arrhythmias
Pituitary
Hormones
ADH
Diabetes
Insipidus
Abdominal
Txt of
hyperacidity
Severe
diarrhea
Alkalization of
the urine to tx
Acute heart
failure
Acute heart
failure
IV or IM:
Sedation,
anxiolysis,
prior to dx,
therapeutic,
or endo proc.
or sx
QRS
Mode of Action
Special Consideration
A direct acting sympathomimetic,
RAPID IV PUSH
stimulates alpha and beta adrenergic
SHOULD NOT BE ADMINISTER THE
receptors resulting in relaxation of
SAME LINE WITH ALKALINE
smooth muscle of the bronchial tree,
SOLUTIONS- may lose its potency
cardiac stimulation and dilatation of
MONITOR CARDIAC rhythm
skeletal muscle vasculature
Competitively
blocks
the
muscarinic RAPID IV PUSH over 1 min
receptors in peripheral tissues such as heart, SLOWER than 1 min may cause
intestines, bronchial muscles, iris and paradoxical bradycardia that
secretory glands
may last 2 minutes
RAPID IV PUSH over 1-3 seconds into a CENTRAL or LARGE PERIPHERAL vein
Follow each dose with 20cc SALINE FLUSH and elevate arm for 10-20secs to ensure
injection reaches systemic circulation
Stimulates
dopaminergic
receptors at
lower doses
producing renal
and mesenteric
Increases
contractility and
heart rate by
stimulating
Beta adrenergic
receptors in
Precautions:
COPD, CHF, chronc renal failure, chills, debilitated, neonates
Flumazenil
Furosemide
Hypertension
Edema
50% Dextrose
Hypoglycemia
Hyperkalemia
Propofol
Diazepam
KCL
Naloxone
MgSO4
Benzodiazepi
ne receptor
antagonists
Anticonvulsant
Antiarrhythmics
Narcotic
antagonist;
Antidote.
suspected
opioid
induced
hypok+, c / s
metabolic alkalo
sis; in dig .intox
prevention risk
if hypokalemia
e.g., dig. pts
/pts w/sig cardiac
Partial
&
Generalized
tonic
clonic
seizures
Severe
Anxiety
Benzodiazepine
-induced
depression of
the ventilatory
responses to
hypercapnia
and hypoxia
Inhibits
reabsorption of
Na and chloride
mainly in the
medullary
portion of the
ascending loopof
Source
calories
and
water
for
hydration
Promotes
glycogen
Decreased
acetylcholine
released
Reverses
opioid-induced
sleep
or
sedation,
increases
RR,
raises BP to
intracellular
cation of
tissues,
participates in a
no, of physio
process
Enhances
the
effect
of
neurotransmitte
r GABA leading
to
CNS
depression
Contraindications
Control of ICP or status epilepticus. Signs of serious cyclic antidep.
overdose
Give through freely running IV infusion into large vein
Instruct to avoid alcohol and non-prescription drugs for 1-24 hrs.
SLOW IV PUSH over 1-2 minutes
DO NOT MIX WITH HIGHLY ACIDIC solution
DO NOT EXPOSE TO LIGHT
Administer SLOW IV PUSH into a LARGE PERIPHERAL VEIN to prevent phlebitis and
sclerosis of vein
MONITOR CAPILLARY BLOOD GLUCOSE
Contraindications
Heart block and myocardial damage
Toxemia of pregnancy
Management Monitor I&O. make sure urine output is 100 ml or more in 4 hrs pd
before each dose
Take appropriate seizure precautions
Maintain clear airway. Obtain weight of children to calculate drug dosage.
Monitor v/s.
Assess for increase pain with reversal opiate.
CI w/ allergy to aspirin
Caution patient that expanded wax matrix capsules will be found in the stool
Report tingling of the hands or feet, unusual tiredness or weakness, feeling of heaviness in the
legs, severe nausea, and vomiting, abdominal pain, black or tarry stools.
Monitor cardiac rhythm carefully during IV administration
SLOW IV PUSH over a minimum of 1 minute into a LARGE PERIPHERAL VEIN to prevent
venous irritation
Observe safety measure